Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Diabetes AND Lantus (Insulin glargine) AND Insulin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    168 result(s) found for: Diabetes AND Lantus (Insulin glargine) AND Insulin. Displaying page 8 of 9.
    « Previous 1  2  3  4  5  6  7  8  9  Next»
    EudraCT Number: 2012-000829-44 Sponsor Protocol Number: H9X-MC-GBDX Start Date*: 2012-09-05
    Sponsor Name:Eli Lilly and Company
    Full Title: A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide with Insulin Glargine on Glycemic Control in Patients with Type 2 Diabetes and Moderate or Severe Chroni...
    Medical condition: Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038359 - Renal and urinary disorders 10064848 Chronic kidney disease LLT
    14.1 10027433 - Metabolism and nutrition disorders 10067585 Type 2 diabetes mellitus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2017-004047-20 Sponsor Protocol Number: NN1250-4419 Start Date*: 2018-08-28
    Sponsor Name:Novo Nordisk A/S
    Full Title: A randomised, cross-over, open-label, multi-centre trial comparing the effect of insulin degludec and insulin glargine 100U/mL, with or without OADs in subjects with type 2 diabetes using flash glu...
    Medical condition: Diabetes Mellitus, Type 2
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004861 10045242 Type II diabetes mellitus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2004-002730-19 Sponsor Protocol Number: HOE 901/3509 Start Date*: 2005-01-26
    Sponsor Name:AVENTIS PHARMA S.P.A.
    Full Title: see above
    Medical condition: Type 2 diabetes mellitus
    Disease: Version SOC Term Classification Code Term Level
    6.1 10012602 HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-003480-21 Sponsor Protocol Number: ClinDiab-03 Start Date*: 2012-11-05
    Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel
    Full Title: An open, single-centre, non-controlled feasibility study on the performance of a tablet based workflow and decision support system with incorporated software algorithm used for glycaemic management...
    Medical condition: Diabetes mellitus type 2
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2005-003415-71 Sponsor Protocol Number: NN2211-1697 Start Date*: 2006-02-24
    Sponsor Name:Novo Nordisk A/S
    Full Title: Liraglutide Effect and Action in Diabetes (LEAD-5): Effects on glycaemic control after once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and ...
    Medical condition: Diabetes Mellitus.
    Disease: Version SOC Term Classification Code Term Level
    8,0 10012601 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) GB (Completed) SK (Completed) FI (Completed) DK (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-004963-42 Sponsor Protocol Number: F3Z-US-IOOV Start Date*: 2006-02-02
    Sponsor Name:LILLY S.A.
    Full Title: Estudio DURABLE: Evaluación de la DURAbilidad de la eficacia de insulina Basal frente a insulina Lispro de baja mEzclaDurabilidad de la insulina lispro de baja mezcla (insulina lispro LM) administr...
    Medical condition: Diabetes Mellitus tipo II
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) HU (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2007-003393-25 Sponsor Protocol Number: LANTU_L_02673 Start Date*: 2007-11-21
    Sponsor Name:sanofi-aventis, s.r.o.
    Full Title:
    Medical condition: Type 2 diabetes mellitus
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2009-014739-19 Sponsor Protocol Number: I2R-MC-BIAC Start Date*: 2010-01-27
    Sponsor Name:Lilly S.A.
    Full Title: Estudio en fase 2 de LY2605541 comparado con insulina Glargina para el tratamiento de pacientes con Diabetes Mellitus tipo 2. A Phase 2 Study of LY2605541 Compared with Insulin Glargine in the Tre...
    Medical condition: Diabetes Mellitus tipo 2
    Disease: Version SOC Term Classification Code Term Level
    9 10053247 Insulin-requiring type 2 diabetes mellitus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2008-006251-46 Sponsor Protocol Number: V4ByIns Start Date*: Information not available in EudraCT
    Sponsor Name:Institute of Diabetes “Gerhardt Katsch”
    Full Title: Prediction of the efficacy of exenatide treatment in suboptimally controlled type 2 diabetic patients by “Metabolic Fingerprint” and evidence-based KADIS® decision support: a clinical pilot trial
    Medical condition: the trial will be performed in a total of 58 male and female patients with type 2 diabetes who will be assigned to two groups, receiving either exenatide or insulin glargine
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-000686-30 Sponsor Protocol Number: LIMBISCHEMIA Start Date*: 2008-02-26
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: Effect of glicemia normalization in fasting conditions by insulinic intensive treatment on frequency of restenosis after periferic angioplastic in patients affected by diabetes mellitus type II.
    Medical condition: diabetes mellitus type II
    Disease: Version SOC Term Classification Code Term Level
    9.1 10049746 Insulin-requiring type II diabetes mellitus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000305-35 Sponsor Protocol Number: MKC-T1-102 Start Date*: 2006-06-23
    Sponsor Name:MannKind Corporation
    Full Title: A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial I...
    Medical condition: Diabetes mellitus type II
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012601 Diabetes mellitus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000306-23 Sponsor Protocol Number: MKC-T1-009 Start Date*: 2006-07-14
    Sponsor Name:MannKind Corporation
    Full Title: A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 1 Diabetes Receiving Subcutaneous Basal Insulin and Prandial I...
    Medical condition: Diabetes mellitus type I
    Disease: Version SOC Term Classification Code Term Level
    7.1 10012601 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-018172-33 Sponsor Protocol Number: LANTU_C_04589 Start Date*: 2010-06-18
    Sponsor Name:SANOFI AVENTIS GROUPE
    Full Title: A 24-week, open, multicenter, comparative study of 2 strategies (including insulin glargine versus premixed insulin) for the therapeutic management of patients with type 2 diabetes failing oral agents
    Medical condition: Type 2 diabetes failing lifestyle management and oral agents
    Disease: Version SOC Term Classification Code Term Level
    12.1 10063624 Type II diabetes mellitus inadequate control LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) AT (Completed) ES (Completed) IT (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2008-000516-32 Sponsor Protocol Number: LANTU_C_02761 Start Date*: 2008-08-04
    Sponsor Name:sanofi aventis Groupe
    Full Title: Superiority study of insulin glargine over sitagliptin in insulin-naïve patients with type 2 diabetes treated with metformin and not adequately controlled
    Medical condition: Type 2 diabetes treated with metformin and not adequately controlled
    Disease: Version SOC Term Classification Code Term Level
    9.1 10063624 Type II diabetes mellitus inadequate control LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) PT (Completed) AT (Completed) ES (Completed) GB (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2004-002731-62 Sponsor Protocol Number: HMR1964A/3514 Start Date*: 2005-06-28
    Sponsor Name:AVENTIS PHARMA S.P.A.
    Full Title: OPTIMISATION OF INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS BY TELECARE ASSISTANCE FOR SELF MONITORING OF BLOOD GLUCOSE ELEONOR STUDY
    Medical condition: TYPE 2 DIABETES MELLITUS
    Disease: Version SOC Term Classification Code Term Level
    6.1 10012602 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-005061-36 Sponsor Protocol Number: F3Z-EW-S020 Start Date*: 2008-01-25
    Sponsor Name:Lilly S.A.
    Full Title: Comparación de un régimen de insulina lispro premezclada (proporción baja, 25/75; y proporción media, 50/50) con un régimen de inyecciones separadas de insulina basal y en bolos, en pacientes con d...
    Medical condition: Diabetes Mellitus tipo 2
    Disease: Version SOC Term Classification Code Term Level
    9.1 10063624 Type II diabetes mellitus inadequate control LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) PT (Completed)
    Trial results: View results
    EudraCT Number: 2015-003761-28 Sponsor Protocol Number: VP-00525 Start Date*: 2015-12-22
    Sponsor Name:Calibra Medical, Inc.
    Full Title: GLYCEMIC CONTROL AND TREATMENT SATISFACTION USING FINESSE VERSUS PEN FOR INITIATING BOLUS INSULIN DOSING IN TYPE 2 DIABETES MELLITUS PATIENTS NOT ACHIEVING GLYCEMIC TARGETS ON BASAL INSULIN WITH/WI...
    Medical condition: Type 2 Diabetes Mellitus (T2DM)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002729-34 Sponsor Protocol Number: HOE 901/4053 Start Date*: 2005-06-07
    Sponsor Name:AVENTIS PHARMA S.P.A.
    Full Title: PILOT STUDY FOR THE EVALUATION OF THE EFFECTS OF INSULIN TREATMENT ON MYOCARDIAL FUNCTION, PERFUSION, AND GLUCOSE METABOLISM IN PATIENTS WITH PRIMARY LEFT VENTRICULAR DYSFUNCTION AND TYPE 2 DIABETES
    Medical condition: Type 2 diabetes mellitus
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012654 Diabetic complications cardiovascular HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-002519-28 Sponsor Protocol Number: F3Z-MC-IOOX Start Date*: 2006-10-01
    Sponsor Name:Lilly S.A.
    Full Title: Ensayo PRIME DT2: Regímenes prandiales-basales de Insulina para mejorar la glucemia post-pandrial en Diabetes Tipo 2.Comparación de dos enfoques con terapia basal y en bolo en pacientes con Diabete...
    Medical condition: Diabetes tipo II
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing) GR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-006179-20 Sponsor Protocol Number: INSULINE Start Date*: 2013-01-04
    Sponsor Name:Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge.
    Full Title: Comparative randomized clinical trial between insulin analogues and human insulin in hospitalized patients treated with enteral nutrition and who present hyperglycemia. INSULINE study.
    Medical condition: Pacients receiving enteral nutrition and who present hyperglycemia.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 24 10:01:20 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA